0
The following are the main findings from the report analyzing the 2020–2021 harmonised antimicrobial resistance (AMR) monitoring of Salmonella spp., Campylobacter jejuni and C. coli in humans and food‐producing animals (broilers, laying hens and turkeys, fattening pigs and bovines under 1 year of age) and relevant meat thereof:
AMR in Campylobacter (particularly in C. coli) and in some strains of Salmonella bacteria remains high. Campylobacteriosis was the most reported zoonosis in the EU in 2021 and the most frequently reported cause of foodborne illness. Campylobacter bacteria from humans and food-producing animals (poultry, fattening turkeys, fattening pigs and calves) continue to show very high resistance to ciprofloxacin, a commonly used antimicrobial in humans.
Combined resistance to critically important antimicrobials - defined as resistance to two different antimicrobials – was found to be low, in general, in Salmonella, Campylobacter and E. coli.
While individual variations across the EU were found, key outcome indicators show that significant progress has been made in reducing AMR in food-producing animals in several Member States.
The reporting of a number of CP-producing E. coli isolates (harbouring blaOXA-48, blaOXA-181, and blaNDM-5 genes) in pigs, bovines and meat thereof by a limited number of Member States in 2021, requests a thorough follow-up.
March 6, 2023/ EFSA/ European Union.
https://www.efsa.europa.eu
